PRX-03140
- Generic Name
- PRX-03140
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H27N3O3S
- CAS Number
- 869493-21-0
- Unique Ingredient Identifier
- 7QGN8QXG7I
- Indication
Investigated for use/treatment in alzheimer's disease and memory loss.
- Associated Conditions
- -
- Associated Therapies
- -
Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder
- First Posted Date
- 2011-12-15
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Resilience Government Services, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT01492699
- Locations
- ๐บ๐ธ
Sarkis Clinical Trials, Gainesville, Florida, United States
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
- Conditions
- Interventions
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 236
- Registration Number
- NCT00693004
- Locations
- ๐บ๐ธ
Barrow Neurological Institute, Phoenix, Arizona, United States
๐บ๐ธMeridien Research, St. Petersburg, Florida, United States
๐บ๐ธTorrance Clinical Research, Torrance, California, United States
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 420
- Registration Number
- NCT00672945
- Locations
- ๐บ๐ธ
Bradenton Research Center, Bradenton, Florida, United States
๐บ๐ธBerma Research Group, Plantation, Florida, United States
๐บ๐ธMaine Neurology, Scarborough, Maine, United States
Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept
- Conditions
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2008-01-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT00384423
- Locations
- ๐บ๐ธ
Southwest CLinical Research, Rancho Mirage, California, United States
๐บ๐ธComprehensive NeuroScience, Inc, St. Petersburg, Florida, United States
๐บ๐ธAtlanta Center for Medical Research, Atlanta, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.